Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03547050 · ClinicalTrials.gov registry record
Rolandic Epilepsy Genomewide Association International Study
A clinical trial, sponsored by King's College London.
- Completed
- Registry status
- 210
- Enrollment target
NCT03547050 is a clinical trial that has completed, run by King's College London. The registered enrollment target is 210 participants.
The verdict
NCT03547050 has completed, sponsored by King's College London.
- COMPLETED
- Registry status
- 210 participants
- Enrollment target
Study Summary
We have discovered a small change in the genetic code which increases the risk of the brainwave abnormality that is found in rolandic epilepsy. We now wish to confirm this using a second much larger sample of patients. We will investigate the other genetic changes that cause people with the brainwave abnormality to develop seizures, as well as problems with speech, coordination, attention and learning.
Interventions
- OTHER Blood draw
- OTHER Existing samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2023-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03547050
The ClinicalTrials.gov registry entry for NCT03547050 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is King's College London, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT03547050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03547050 about?
NCT03547050 is a clinical study titled "Rolandic Epilepsy Genomewide Association International Study". We have discovered a small change in the genetic code which increases the risk of the brainwave abnormality that is found in rolandic epilepsy. We now wish to confirm this using a second much larger sample of patients. We will investigate the other genetic changes that cause people with the brainwav...
What is the current status of trial NCT03547050?
This trial is currently completed. The enrollment target is 210 participants. The study started on 2018-06-01. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT03547050?
The interventions under investigation include: Blood draw (OTHER), Existing samples (OTHER).
Who is sponsoring clinical trial NCT03547050?
This trial is sponsored by King's College London, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.